home / stock / nrbo / nrbo news

NRBO News and Press, NeuroBo Pharmaceuticals Inc. From 05/20/20

Stock Information
Company Name: NeuroBo Pharmaceuticals Inc.
Stock Symbol: NRBO
Market: NASDAQ
Website: neurobopharma.com
Menu
NRBO NRBO Quote NRBO Short NRBO News NRBO Articles NRBO Message Board
Get NRBO Alerts

News, Short Squeeze, Breakout and More Instantly...
NRBO - NeuroBo Pharmaceuticals EPS misses by $0.20

NeuroBo Pharmaceuticals (NASDAQ: NRBO ): Q1 GAAP EPS of -$0.30 misses by $0.20 . More news on: NeuroBo Pharmaceuticals, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...

NRBO - NeuroBo Pharmaceuticals Reports First Quarter 2020 Financial Results

BOSTON , May 20, 2020 /PRNewswire/ --  NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced financial...

NRBO - NeuroBo Pharmaceuticals Announces Issuance of U.S. Patent, Providing Broad Coverage of NB-02 for Neurodegenerative Disorders

BOSTON , April 21, 2020 /PRNewswire/ --  NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced that...

NRBO - NeuroBo Pharmaceuticals Announces Closing of $7.5 Million Registered Direct Offering

BOSTON , April 16, 2020 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced that it has ...
NRBO - AR, CORR, SPCE and NBEV among midday movers

Gainers: NeuroMetrix (NASDAQ: NURO ) +147% . More news on: NeuroMetrix, Inc., Sonnet BioTherapeutics Holdings, Inc., Neovasc Inc., Stocks on the move, , Read more ...

NRBO - NeuroBo Pharma down 37% on equity offering

NeuroBo Pharmaceuticals ( NRBO -36.9% ) has entered into a definitive agreement for the purchase and sale in a registered direct offering of 750,000 common shares, at a purchase price of $10.00 per share, for gross proceeds of $7.5M. More news on: NeuroBo Pharmaceuticals, Inc., He...

NRBO - NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering

BOSTON , April 14, 2020 /PRNewswire/ --  NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced that it...
NRBO - NeuroBo Pharmaceuticals reports FY results

NeuroBo Pharmaceuticals (NASDAQ: NRBO ): FY GAAP EPS of -$4.08. More news on: NeuroBo Pharmaceuticals, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...

NRBO - NeuroBo Pharmaceuticals Reports Year End 2019 Financial Results and Provides Corporate Strategic Update

BOSTON , March 30, 2020 /PRNewswire/ --  NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced financi...

NRBO - SPCE, I, FLR and WWR among midday movers

Gainers: Bellerophon Therapeutics (NASDAQ: BLPH )  +144% . More news on: Bellerophon Therapeutics, Inc., Brickell Biotech, Inc., Wanda Sports Group Company Limited, Stocks on the move, , Read more ...

Previous 10 Next 10